SYN-TECH Chem. & Pharm. Co., Ltd. Stock price

Equities

1777

TW0001777001

Pharmaceuticals

End-of-day quote Taipei Exchange 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
83.7 TWD -0.12% Intraday chart for SYN-TECH Chem. & Pharm. Co., Ltd. -0.48% -1.76%
Sales 2022 986M 30.76M Sales 2023 1.11B 34.77M Capitalization 3.8B 118M
Net income 2022 295M 9.2M Net income 2023 251M 7.83M EV / Sales 2022 3.27 x
Net cash position 2022 528M 16.47M Net cash position 2023 343M 10.7M EV / Sales 2023 3.1 x
P/E ratio 2022
12.7 x
P/E ratio 2023
15.2 x
Employees 220
Yield 2022
3.56%
Yield 2023
4.11%
Free-Float 40.69%
More Fundamentals * Assessed data
Dynamic Chart
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Approves Cash Dividend, Payable on August 18, 2023 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Appointment of Corporate Governance Officer CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Operating Revenue Results for the Month and Nine Months Ended September 30, 2022 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Executive Changes CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Change of Research and Development Officer CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Cash Dividend, Payable on August 19, 2022 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 week-0.36%
Current month+2.20%
1 month+2.20%
3 months-1.99%
6 months-5.10%
Current year-1.64%
More quotes
1 week
82.90
Extreme 82.9
84.50
1 month
81.80
Extreme 81.8
84.50
Current year
81.70
Extreme 81.7
86.10
1 year
81.70
Extreme 81.7
99.20
3 years
63.30
Extreme 63.3
122.00
5 years
62.80
Extreme 62.8
122.00
10 years
58.10
Extreme 58.1
122.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 95-07-31
Chief Tech/Sci/R&D Officer - 82-08-26
Members of the board TitleAgeSince
Director/Board Member - -
Chairman - 03-03-16
Chief Tech/Sci/R&D Officer - 82-08-26
More insiders
Date Price Change Volume
24-03-27 83.7 -0.12% 6 520
24-03-27 83.8 0.00% 10,050
24-03-26 83.8 +0.48% 40,898
24-03-25 83.4 +0.36% 17,062
24-03-22 83.1 -0.24% 17,138

End-of-day quote Taipei Exchange, March 26, 2024

More quotes
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Company's main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
More about the company
  1. Stock
  2. Equities
  3. Stock SYN-TECH Chem. & Pharm. Co., Ltd. - Taipei Exchange